I see them as competing with PGL in this space of primary liver cancer, so if they can't make it to the next level I guess it is good news for PGL.
- Forums
- ASX - By Stock
- PGL
- bioalliance pharma suspends phase ii iii trial
bioalliance pharma suspends phase ii iii trial, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
|
|||||
Last
44.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.28M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1146107 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
44.0¢ | 1830 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1146107 | 0.440 |
3 | 145300 | 0.435 |
1 | 55597 | 0.425 |
1 | 83416 | 0.420 |
1 | 16000 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.440 | 1830 | 2 |
0.450 | 121719 | 5 |
0.460 | 16399 | 1 |
0.490 | 21811 | 2 |
0.500 | 2000 | 1 |
Last trade - 07.33am 12/07/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |
Day chart unavailable